Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nadia Noreen, Dil Saima, Naveed Irum, Rana Jawad Asghar, Asad Ullah Faiz, Naseer Mohiuddin, Mumtaz Ali Khan, Naveed Ullah Khan, Farida Khudaidad & Fawad Khalid Khan. (2020) ‘Characterisation of suspected Crimean-Congo Haemorrhagic Fever (CCHF) cases in a public sector hospital Islamabad’. Global Security: Health, Science and Policy 5:1, pages 85-92.
Read now
Read now
Articles from other publishers (65)
Büşra Ahata & Günseli Bayram Akçapınar. (2023) CCHFV vaccine development, current challenges, limitations, and future directions. Frontiers in Immunology 14.
Crossref
Crossref
Aykut Ozdarendeli. (2023) Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development. Diagnostics 13:16, pages 2708.
Crossref
Crossref
David W. Hawman & Heinz Feldmann. (2023) Crimean–Congo haemorrhagic fever virus. Nature Reviews Microbiology 21:7, pages 463-477.
Crossref
Crossref
Tong Chen, Zhe Ding, Jiaming Lan & Gary Wong. (2023) Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Gabriel Soares Guerra, Diego Barriales, Gema Lorenzo, Sandra Moreno, Juan Anguita, Alejandro Brun & Nicola G.A. Abrescia. (2023) Immunization with a small fragment of the Schmallenberg virus nucleoprotein highly conserved across the Orthobunyaviruses of the Simbu serogroup reduces viremia in SBV challenged IFNAR-/- mice. Vaccine 41:20, pages 3275-3284.
Crossref
Crossref
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Furqan Munir, Amna Shakoor, Zia ud Din Sindhu & Muhammad Tahir Aleem. (2023) Crimean-Congo hemorrhagic fever: Immunopathogenesis and recent advances in the development of vaccines. Microbial Pathogenesis 177, pages 106054.
Crossref
Crossref
Jack E. Saunders, Ciaran Gilbride, Stuart Dowall, Susan Morris, Marta Ulaszewska, Alexandra J. Spencer, Emma Rayner, Victoria A. Graham, Emma Kennedy, Kelly Thomas, Roger Hewson, Sarah C. Gilbert, Sandra Belij-Rammerstorfer & Teresa Lambe. (2023) Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model. eBioMedicine 90, pages 104523.
Crossref
Crossref
Yong-Liang Hu, Lian-Qing Zhang, Xiao-Qian Liu, Wei Ye, Yue-Xi Zhao, Liang Zhang, Zun-Xian Qiang, Lin-Xuan Zhang, Ying-Feng Lei, Dong-Bo Jiang, Lin-Feng Cheng & Fang-Lin Zhang. (2023) Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Rahat Alam, Abdus Samad, Foysal Ahammad, Suza Mohammad Nur, Ahad Amer Alsaiari, Raihan Rahman Imon, Md. Enamul Kabir Talukder, Zulkar Nain, Md. Mashiar Rahman, Farhan Mohammad & Tomasz M. Karpiński. (2023) In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever. BMC Medicine 21:1.
Crossref
Crossref
David W. Hawman, Kimberly Meade-White, Shanna Leventhal, Sofia Appelberg, Gustaf Ahlén, Negin Nikouyan, Chad Clancy, Brian Smith, Patrick Hanley, Jamie Lovaglio, Ali Mirazimi, Matti Sällberg & Heinz Feldmann. (2023) Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Molecular Therapy 31:2, pages 387-397.
Crossref
Crossref
Yasemin CosgunAhmet AydemirHakan HedefAyten Öz KamilogluOliver KlemensErik LattweinJulia Maria KlemensSandra Saschenbrecker, Katja SteinhagenGulay Korukluoglu. (2023) Evaluation of Nucleoprotein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Acute Crimean–Congo Hemorrhagic Fever Virus Infections in a Turkish Population. Vector-Borne and Zoonotic Diseases 23:1, pages 44-53.
Crossref
Crossref
Stuart D. Dowall, Leo P. Graves, Emma Kennedy, Victoria A. Graham, Riyadh A. Alakeely, Adam Chambers, Robert D. Possee, Linda A. King & Roger Hewson. (2023) Development of humanised antibodies for Crimean-Congo Haemorrhagic fever virus: Comparison of hybridoma-based versus phage library techniques. Journal of Immunological Methods 512, pages 113405.
Crossref
Crossref
Felicity Jane Burt & Dominique Goedhals. 2022. Zoonoses: Infections Affecting Humans and Animals. Zoonoses: Infections Affecting Humans and Animals
1
27
.
Ian A. Durie, Zahra R. Tehrani, Elif Karaaslan, Teresa E. Sorvillo, Jack McGuire, Joseph W. Golden, Stephen R. Welch, Markus H. Kainulainen, Jessica R. Harmon, Jarrod J. Mousa, David Gonzalez, Suzanne Enos, Iftihar Koksal, Gurdal Yilmaz, Hanife Nur Karakoc, Sanaz Hamidi, Cansu Albay, Jessica R. Spengler, Christina F. Spiropoulou, Aura R. Garrison, Mohammad M. Sajadi, Éric Bergeron & Scott D. Pegan. (2022) Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus. Nature Communications 13:1.
Crossref
Crossref
Megan C. Mears & Dennis A. Bente. (2022) In silico Design of a Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Multi-Epitope Antigen for Vaccine Development. Zoonoses 2:1.
Crossref
Crossref
Boushab Mohamed Boushab, Pauline K Yanogo, Djibril Barry, Hacen Ahmed Benane, Ahmed El Bara, Moussa Abdellah, Leonardo K Basco & Nicolas Meda. (2022) Investigation Around Cases of Crimean-Congo Hemorrhagic Fever—Mauritania, 2022. Open Forum Infectious Diseases 9:10.
Crossref
Crossref
Shanna S. Leventhal, Kimberly Meade-White, Deepashri Rao, Elaine Haddock, Jacqueline Leung, Dana Scott, Jacob Archer, Samantha Randall, Jesse H. Erasmus, Heinz Feldmann & David W. Hawman. (2022) Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. eBioMedicine 82, pages 104188.
Crossref
Crossref
Qi Wang, Shen Wang, Zhikang Shi, Zhengrong Li, Yongkun Zhao, Na Feng, Jinhao Bi, Cuicui Jiao, Entao Li, Tiecheng Wang, Jianzhong Wang, Hongli Jin, Pei Huang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2022) GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice. Viruses 14:8, pages 1664.
Crossref
Crossref
Md. Ashik Imran, Md. Rubiath Islam, Akash Saha, Shahida Ferdousee, Moshiul Alam Mishu & Ajit Ghosh. (2022) Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach. International Journal of Peptide Research and Therapeutics 28:4.
Crossref
Crossref
Lynda Coughlan, Eric J. Kremer & Dmitry M. Shayakhmetov. (2022) Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens. Molecular Therapy 30:5, pages 1822-1849.
Crossref
Crossref
Emad Behboudi, Ehsan Kakavandi, Vahideh Hamidi-Sofiani, Arefeh Ebrahimian & Mohammad Shayestehpour. (2022) Crimean-Congo hemorrhagic fever virus vaccine: past, present, and future. Reviews in Medical Microbiology 33:2, pages 109-116.
Crossref
Crossref
Sergio E. Rodriguez, David W. Hawman, Teresa E. Sorvillo, T. Justin O'Neal, Brian H. Bird, Luis L. Rodriguez, Éric Bergeron, Stuart T. Nichol, Joel M. Montgomery, Christina F. Spiropoulou & Jessica R. Spengler. (2022) Immunobiology of Crimean-Congo hemorrhagic fever. Antiviral Research 199, pages 105244.
Crossref
Crossref
Sazzad Shahrear & Abul Bashar Mir Md Khademul Islam. (2022) Immunoinformatics guided modeling of CCHF_GN728, an mRNA-based universal vaccine against Crimean-Congo hemorrhagic fever virus. Computers in Biology and Medicine 140, pages 105098.
Crossref
Crossref
Thomas Tipih, Mark Heise & Felicity Jane Burt. (2021) Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean–Congo Hemorrhagic Fever Virus Nucleoprotein. Vaccines 9:12, pages 1491.
Crossref
Crossref
Elif Karaaslan, Nesibe Selma Çetin, Merve Kalkan-Yazıcı, Sevde Hasanoğlu, Faruk Karakeçili, Aykut Özdarendeli, Ahmet Kalkan, Ali Osman Kılıç & Mehmet Ziya Doymaz. (2021) Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV). PLOS Neglected Tropical Diseases 15:12, pages e0009973.
Crossref
Crossref
L. F. Stovba, V. T. Krotkov, S. A. Melnikov, D. I. Paveliev, N. K. Chernikova & S. V. Borisevich. (2021) Using the vaccinia virus MVA strain for developing recombinant vector vaccines against current arboviral infections. Journal of microbiology, epidemiology and immunobiology 98:5, pages 579-587.
Crossref
Crossref
Tomoki Yoshikawa. (2021) Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers. Vaccine 39:41, pages 6174-6181.
Crossref
Crossref
Engin Berber, Nurettin Çanakoğlu, Şükrü Tonbak & Aykut Ozdarendeli. (2021) Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection. Heliyon 7:10, pages e08161.
Crossref
Crossref
Ergin SAHİN, Arzu ÇÖLERİ CİHAN, Touraj ALİGHOLİPOUR, Katalin FOLDES, Evren Doruk ENGİN & Aykut ÖZKUL. (2021) Assessment of the Immunogenicity and Protective Aspects of a DNA Vaccine Targeting Crimean Congo Hemorrhagic Fever Virus Glycoprotein GcKırım Kongo Kanamalı Ateşi Virüsü Glikoprotein Gc’yi Hedef Alan Bir DNA Aşısının Bağışıklık ve Koruyuculuk Sağlama Özelliklerinin Değerlendirilmesi. Düzce Tıp Fakültesi Dergisi 23:1, pages 66-75.
Crossref
Crossref
Ciaran Gilbride, Jack Saunders, Hannah Sharpe, Emmanuel Atangana Maze, Georgina Limon, Anna Barbara Ludi, Teresa Lambe & Sandra Belij-Rammerstorfer. (2021) The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever. Frontiers in Immunology 12.
Crossref
Crossref
Tomoki Yoshikawa, Satoshi Taniguchi, Hirofumi Kato, Naoko Iwata-Yoshikawa, Hideki Tani, Takeshi Kurosu, Hikaru Fujii, Natsumi Omura, Miho Shibamura, Shumpei Watanabe, Kazutaka Egawa, Takuya Inagaki, Satoko Sugimoto, Supranee Phanthanawiboon, Shizuko Harada, Souichi Yamada, Shuetsu Fukushi, Shigeru Morikawa, Noriyo Nagata, Masayuki Shimojima & Masayuki Saijo. (2021) A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome. PLOS Pathogens 17:2, pages e1008859.
Crossref
Crossref
Md. Shakil Ahmed Khan, Zulkar Nain, Shifath Bin Syed, Faruq Abdulla, Mohammad Ali Moni, Md. Moinuddin Sheam, Mohammad Minnatul Karim & Utpal Kumar Adhikari. (2021) Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus. Molecular and Cellular Probes 55, pages 101693.
Crossref
Crossref
Boniface Pongombo Lombe, Hiroko Miyamoto, Takeshi Saito, Reiko Yoshida, Rashid Manzoor, Masahiro Kajihara, Masayuki Shimojima, Shuetsu Fukushi, Shigeru Morikawa, Tomoki Yoshikawa, Takeshi Kurosu, Masayuki Saijo, Qing Tang, Justin Masumu, David Hawman, Heinz Feldmann & Ayato Takada. (2021) Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis. Scientific Reports 11:1.
Crossref
Crossref
Seyit Ali Büyüktuna & Halef Okan Doğan. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
207
219
.
David W. Hawman, Gustaf Ahlén, K. Sofia Appelberg, Kimberly Meade-White, Patrick W. Hanley, Dana Scott, Vanessa Monteil, Stephanie Devignot, Atsushi Okumura, Friedemann Weber, Heinz Feldmann, Matti Sällberg & Ali Mirazimi. (2020) A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nature Microbiology 6:2, pages 187-195.
Crossref
Crossref
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Ahmet Kalkan & Aykut Ozdarendeli. (2020) Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model. PLOS Neglected Tropical Diseases 14:11, pages e0008834.
Crossref
Crossref
Enrica Serretiello, Roberta Astorri, Annalisa Chianese, Debora Stelitano, Carla Zannella, Veronica Folliero, Biagio Santella, Marilena Galdiero, Gianluigi Franci & Massimiliano Galdiero. (2020) The emerging tick-borne Crimean-Congo haemorrhagic fever virus: A narrative review. Travel Medicine and Infectious Disease 37, pages 101871.
Crossref
Crossref
Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Daniel J. Deer, Karla A. Fenton & Thomas W. Geisbert. (2020) Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys. PLOS Neglected Tropical Diseases 14:8, pages e0008637.
Crossref
Crossref
Ki Beom Park, Yong Hun Jo, Nam‐Yeon Kim, Wook‐Gyo Lee, Hee‐Il Lee, Shin‐Hyeong Cho, Bharat Bhusan Patnaik & Yeon Soo Han. (2020) Tick‐borne viruses: Current trends in large‐scale viral surveillance. Entomological Research 50:8, pages 379-392.
Crossref
Crossref
Teresa E. Sorvillo, Sergio E. Rodriguez, Peter Hudson, Megan Carey, Luis L. Rodriguez, Christina F. Spiropoulou, Brian H. Bird, Jessica R. Spengler & Dennis A. Bente. (2020) Towards a Sustainable One Health Approach to Crimean–Congo Hemorrhagic Fever Prevention: Focus Areas and Gaps in Knowledge. Tropical Medicine and Infectious Disease 5:3, pages 113.
Crossref
Crossref
Thomas TipihFelicity Jane Burt. (2020) Crimean–Congo Hemorrhagic Fever Virus: Advances in Vaccine Development. BioResearch Open Access 9:1, pages 137-150.
Crossref
Crossref
Marko Zivcec, Christina F. Spiropoulou & Jessica R. Spengler. (2020) The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies. Antiviral Research 174, pages 104702.
Crossref
Crossref
Ashwin Ashok Raut, Pradeep N. Gandhale, D. Senthil Kumar, Naveen Kumar, Atul Pateriya, Anamika Mishra & Diwakar D. Kulkarni. 2020. Emerging and Transboundary Animal Viruses. Emerging and Transboundary Animal Viruses
255
283
.
P. Fillâtre, M. Revest & P. Tattevin. (2019) Crimean-Congo hemorrhagic fever: An update. Médecine et Maladies Infectieuses 49:8, pages 574-585.
Crossref
Crossref
Mohammad Nadir Sahak, Fatima Arifi & Sayed Ataullah Saeedzai. (2019) Descriptive epidemiology of Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: Reported cases to National Surveillance System, 2016–2018. International Journal of Infectious Diseases 88, pages 135-140.
Crossref
Crossref
Jessica R. Spengler, Stephen R. Welch, Florine E.M. Scholte, JoAnn D. Coleman-McCray, Jessica R. Harmon, Stuart T. Nichol, Éric Bergeron & Christina F. Spiropoulou. (2019) Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine. Antiviral Research 170, pages 104573.
Crossref
Crossref
Touraj Aligholipour Farzani, Katalin Földes, Koray Ergünay, Hakan Gurdal, Aliye Bastug & Aykut Ozkul. (2019) Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines 7:3, pages 115.
Crossref
Crossref
Joseph W. Golden, Charles J. Shoemaker, Michael E. LindquistXiankun Zeng, Sharon P. DayeJanice A. WilliamsJun LiuKayla M. CoffinScott OlschnerOlivier Flusin, Louis A. AltamuraKathleen A. KuehlCollin J. Fitzpatrick, Connie S. Schmaljohn & Aura R. Garrison. (2019) GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Science Advances 5:7.
Crossref
Crossref
Garrison, Smith & Golden. (2019) Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease. Viruses 11:7, pages 590.
Crossref
Crossref
Sergio E. Rodriguez, Robert W. Cross, Karla A. Fenton, Dennis A. Bente, Chad E. Mire & Thomas W. Geisbert. (2019) Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever. Scientific Reports 9:1.
Crossref
Crossref
Muhammad Usman Mirza, Michiel Vanmeert, Matheus Froeyen, Amjad Ali, Shazia Rafique & Muhammad Idrees. (2019) In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors. Scientific Reports 9:1.
Crossref
Crossref
Mokhtar Nosrati, Mandana Behbahani & Hassan Mohabatkar. (2019) Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach. Journal of Biomedical Informatics 93, pages 103160.
Crossref
Crossref
Touraj Aligholipour Farzani, Katalin Földes, Alireza Hanifehnezhad, Burcu Yener Ilce, Seval Bilge Dagalp, Neda Amirzadeh Khiabani, Koray Ergünay, Feray Alkan, Taner Karaoglu, Hurrem Bodur & Aykut Ozkul. (2019) Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models. Viruses 11:3, pages 237.
Crossref
Crossref
Laura T Mazzola & Cassandra Kelly-Cirino. (2019) Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease. BMJ Global Health 4:Suppl 2, pages e001114.
Crossref
Crossref
Marko Zivcec, David Safronetz, Dana P. Scott, Shelly Robertson & Heinz Feldmann. (2018) Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge. PLOS Neglected Tropical Diseases 12:7, pages e0006628.
Crossref
Crossref
Samuel Johnson, Nicholas Henschke, Nicola Maayan, Inga Mills, Brian S Buckley, Artemisia Kakourou & Rachel Marshall. (2018) Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database of Systematic Reviews 2018:6.
Crossref
Crossref
David W. Hawman & Heinz Feldmann. (2018) Recent advances in understanding Crimean–Congo hemorrhagic fever virus. F1000Research 7, pages 1715.
Crossref
Crossref
Dominique Goedhals, Janusz T. Paweska & Felicity J. Burt. (2017) Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. PLOS Neglected Tropical Diseases 11:12, pages e0006149.
Crossref
Crossref
Stuart D. Dowall, Miles W. Carroll & Roger Hewson. (2017) Development of vaccines against Crimean-Congo haemorrhagic fever virus. Vaccine 35:44, pages 6015-6023.
Crossref
Crossref
Samuel Johnson, Nicola Maayan, Inga Mills, Brian S Buckley, Artemisia Kakourou & Rachel Marshall. (2017) Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mehdi Rahpeyma, Alireza Samarbaf-Zadeh, Manoochehr Makvandi, Ata A. Ghadiri, Stuart D. Dowall & Fatemeh Fotouhi. (2017) Expression and characterization of codon-optimized Crimean-Congo hemorrhagic fever virus Gn glycoprotein in insect cells. Archives of Virology 162:7, pages 1951-1962.
Crossref
Crossref
Jessica R. Spengler, Agustín Estrada-Peña, Aura R. Garrison, Connie Schmaljohn, Christina F. Spiropoulou, Éric Bergeron & Dennis A. Bente. (2016) A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus. Antiviral Research 135, pages 31-47.
Crossref
Crossref
Marko Zivcec, Florine Scholte, Christina Spiropoulou, Jessica Spengler & Éric Bergeron. (2016) Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. Viruses 8:4, pages 106.
Crossref
Crossref
Andrea Molinas, Ali Mirazimi, Angelika Holm, Vesa M. Loitto, Karl-Eric Magnusson & Elena Vikstr?m. (2016) Protective role of host aquaporin 6 against Hazara virus, a model for Crimean?Congo hemorrhagic fever virus infection. FEMS Microbiology Letters 363:8, pages fnw058.
Crossref
Crossref